Maria-Cristina Keightley, Duncan P Carradice, Judith E Layton, Luke Pase, Julien Y Bertrand, Johannes G Wittig, A. DAKIC, Andrew P Badrock, Nicholas J Cole, David Traver, Stephen L Nutt, Julia McCoey, Ashley M Buckle, Joan K Heath, Graham J Lieschke. The Pu.1 target gene Zbtb11 regulates neutrophil development through its integrase-like HHCC zinc finger.. Nature communications, 8, 14911 (13pp), 2017. doi: 10.1038/ncomms14911.
Sebastian Carotta, A. DAKIC, Swee Heng Milon Pang, Kylie T Greig, Stephen L Nutt, Li Wu. The transcription factor PU.1 controls dendritic cell development and Flt3 cytokine receptor expression in a dose-dependent manner.. Immunity, 32, 628-641, 2010. doi: 10.1016/j.immuni.2010.05.005.
JM Adams, PN Kelly, A. DAKIC, S Carotta, SL Nutt, A Strasser. Role of "cancer stem cells" and cell survival in tumor development and maintenance.. Cold Spring Harbor symposia on quantitative biology, 73, 451-459, 2008. doi: 10.1101/sqb.2008.73.004.
Shalin H Naik, Priyanka Sathe, Hae-Young Park, Donald Metcalf, Anna I Proietto, A. DAKIC, Sebastian Carotta, M. Bahlo, A. Papenfuss, Jong-Young Kwak, Li Wu, Ken Shortman, Meredith O Keeffe. Development of plasmacytoid and conventional dendritic cell subtypes from single precursor cells derived in vitro and in vivo.. Nature immunology, 8, 1217-1226, 2007. doi: 10.1038/ni1522.
Priscilla N Kelly, A. DAKIC, Jerry M Adams, Stephen L Nutt, Andreas Strasser. Tumor growth need not be driven by rare cancer stem cells.. Science (New York, N.Y.), 317, 337 (1pp), 2007. doi: 10.1126/science.1142596.
A. DAKIC, Li Wu, Stephen L Nutt. Is PU.1 a dosage-sensitive regulator of haemopoietic lineage commitment and leukaemogenesis?. Trends in immunology, 28, 108-114, 2007. doi: 10.1016/j.it.2007.01.006.